Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,943 | -57,829 | -45,892 | -2,006 | -21,300 |
| Depreciation Amortization | 2,205 | 1,841 | 1,335 | 1,273 | 1,175 |
| Accounts payable and accrued liabilities | 991 | 497 | 83 | 327 | -53 |
| Other Working Capital | -3,184 | 3,859 | 2,085 | -25,640 | -18,195 |
| Other Operating Activity | 3,183 | 459 | 769 | 2,589 | 5,853 |
| Operating Cash Flow | $-65,748 | $-51,173 | $-41,620 | $-23,457 | $-32,520 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,000 | 40,008 | 13,596 | 19,338 | 33,818 |
| PPE Investments | -2,014 | -1,861 | -1,197 | -311 | -803 |
| Other Investing Activity | 0 | 0 | -4,000 | 0 | 0 |
| Investing Cash Flow | $-14 | $38,147 | $8,399 | $19,027 | $33,015 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 9,850 | 9,855 | N/A | N/A |
| Debt Repayment | -2,219 | -48 | -45 | -52 | -43 |
| Common Stock Issued | 9,340 | 70,065 | 35,204 | 156 | 9 |
| Other Financing Activity | -45 | -252 | -33 | -36 | -102 |
| Financing Cash Flow | $7,076 | $79,615 | $44,981 | $68 | $-136 |
| Beginning Cash Position | 105,052 | 38,463 | 26,703 | 31,065 | 30,706 |
| End Cash Position | 46,366 | 105,052 | 38,463 | 26,703 | 31,065 |
| Net Cash Flow | $-58,686 | $66,589 | $11,760 | $-4,362 | $359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,748 | -51,173 | -41,620 | -23,457 | -32,520 |
| Capital Expenditure | -2,014 | -1,861 | -1,197 | -311 | -803 |
| Free Cash Flow | -67,762 | -53,034 | -42,817 | -23,768 | -33,323 |